LOTUS™ Valve Superior to Evolut™ R / CoreValve™* In Primary Efficacy Endpoint

LOTUS Valve = 15.8%  v. Evolut R / CoreValve Platform = 26.0%  
Superiority P < 0.001

LOTUS Valve = 16.7%  v. CoreValve Platform = 29.0%     Superiority P < 0.001 LOTUS Valve = 16.7%  v. CoreValve Platform = 29.0%     Superiority P < 0.001